Powered by

Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution

Nov 02, 2020 - GlobeNewswire

BOSTON and DURHAM, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, today announced a strategic collaboration with Synexa Life Sciences, a world-leading expert in biomarker and bioanalytical science, and Drawbridge Health, a healthcare technology company reinventing the blood draw experience, focused on delivering comprehensive sol...